ID: MRFR/MED/0200-HCR | 50 Pages | Author: Rahul Gotadki | June 2023
The Orthopedic Biomaterial Market of asia pacific is expected to reach USD 40,519.52 million by 2030 at 10.5% CAGR during the forecast period 2022-2030. Orthopedic biomaterials are organic or synthetic materials used for the treatment of internal fractures. During the last decade different new techniques and materials are introduced for orthopedic implants and surgeries and biomaterials have found a vital role in it. These biomaterials are used in manufacturing of different implants since they do not evoke any immunological reactions with the body, which makes it a first choice for manufacturing of implants. Increasing demand for the orthopedic biomaterial because of its application in knee and hip replacement surgeries, and increasing incident of medical emergencies drive the Asia Pacific orthopedic biomaterial market.
Introduction of novel implants of titanium has increased the success rate of implant surgeries and also contributed to the growth of the orthopedic market in Asia Pacific. Moreover, increasing number of orthopedic surgeries, increasing aging population, and growing governmental support also drive the Asia Pacific market. However, increasing failure in joints implants, stringent regulatory laws, and high cost of treatment may hinder the growth of Asia Pacific orthopedic biomaterial market during the review period.
Key Players
Some of the major players in Asia Pacific orthopedic biomaterial market: Kyocera Corporation (Japan), Materion Corporation (US), S&V Technologies (Germany), Rayner (UK), InVision Biomedical (US), Covestro (Germany), Invibio Ltd. (U.K.), Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), CeramTec (Germany), Tianjin Walkman Biomaterial Co. (China), Kanghui Holdings (China), Johnson & Johnson Services, Inc. (US), Cam Bioceramics B.V. (Netherland), and Xian Airfoil Technology Co (China).
SegmentationThe orthopedic biomaterials market is segmented on the basis of types of material, applications, and end users. On the basis of types of material, the market is segmented into metals and non-metals. The metals are further segmented into stainless steel, titanium alloy, cobalt alloy, and others. Non-metal are further segmented into ceramic, polymeric, natural biomaterials, and others. The ceramic are sub-segmented into alumina, calcium phosphate, zirconium dioxide, carbon, and others. The polymeric materials are sub-segmented into polymethylmethacrylate (PMMA), polyethylene, silicone, polyester, and other. The natural biomaterials are sub-segmented into collagen, chitin & chitosan, and other
On the basis of applications, the Asia Pacific orthopedic biomaterial market is segmented into joint replacement, fracture fixation devices, tissue fixation, spine implants, viscosupplementation, and other. Joint replacement is sub-segmented into hip replacement, knee replacement, shoulder and elbow replacement, and other. Tissue fixation is sub-segmented into interference screws, suture anchors, and others. Spine implants are further sub-segmented into spine fusion and other. The fracture fixation devices are sub segmented into screws, plates for bones, rods, and other.
On the basis of end users, the Asia Pacific orthopedic biomaterial market is segmented into hospital, clinics, and others.
Regional Analysis
China dominates the Asia Pacific orthopedic biomaterial market owing to increasing prevalence of different orthopedic surgeries in China. Increasing awareness of biodegradable products among the people, rapid research and development and huge aging population in this region have added fuel to the growth of the market. Japan and Australia are other major contributor of the Asia Pacific orthopedic biomaterial market in this region.
Intended Audience
Report Attribute/Metric | Details |
---|---|
Market Size | USD 40,519.52 million |
CAGR | 10.5% |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Product Type, Material Class |
Geographies Covered | North America, Europe, Asia Pacific |
Key Vendors | Stryker (US) CoorsTek Inc. (US) Zimmer Biomet Holdings Inc. (US) Institut Straumann AG (Switzerland) Kyocera Corporation (Japan) Smith & Nephew plc (UK) 3M (US) Nobel Biocare Services AG(Switzerland) Medtronicplc (Ireland) DePuy Synthes (US) |
Key Market Opportunities | Technological advancement in the medical implants market |
Key Market Drivers | Increasing older population leading to an increase in the patient population |
The Asia Pacific Orthopedic Biomaterial Market CAGR would be 10.5% during the forecast period (2022-2030).
End users in the Asia Pacific Orthopedic Biomaterial Market are hospitals, clinics, and others.
China would dominate the Asia Pacific Orthopedic Biomaterial Market.
The applications of the Asia Pacific Orthopedic Biomaterial Market are viscosupplementation, fracture fixation devices, joint replacement, spine implants, tissue fixation, and other
Players involved are Materion Corporation (US), Kyocera Corporation (Japan), InVision Biomedical (US), S&V Technologies (Germany), Rayner (UK), Invibio Ltd. (U.K.), Royal DSM (Netherlands), Covestro (Germany), Corbion N.V. (Netherlands), BASF SE (Germany), Tianjin Walkman Biomaterial Co. (China), CeramTec (Germany), Cam Bioceramics B.V. (Netherland), Johnson & Johnson Services, Inc. (US), Kanghui Holdings (China), and Xian Airfoil Technology Co (China).
Key Questions Answered
Why Choose Market Research Future?